School Readiness Program for Preschoolers with Sickle Cell
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests a program to help preschoolers with sickle cell disease get ready for school. It looks at whether a special learning program can help with skills like paying attention and getting along with others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have sickle cell disease of any type.
- Your child must be enrolled in the Sickle Cell Clinical Research and Intervention Program (SCCRIP) at St. Jude.
- Your child's age must be between 3.5 and 6.5 years old when the study starts.
- English must be the primary language spoken at home.
- Both you (the parent) and your child need to agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects feedback through surveys, interviews, and focus groups from people affected by sickle cell disease. Your input helps the research team improve how genomic and gene-therapy information and needs are understood for patients and caregivers.
This trial tests if a medication called methylphenidate can help children with sickle cell disease who have trouble with attention, focus, or executive function. It aims to see if it can improve daily life and school performance.
This study tests a structured program to help teens with sickle cell disease smoothly transition from pediatric care to adult care, with support for parents or legal guardians. It may help families coordinate care sooner and more confidently during this change.
This Phase 2 study tests a cognitive (thinking) training program to help teens with sickle cell disease prepare for the changes in their care as they grow older. It may help with skills like learning, attention, and planning for transition to adult care.
This study tests a new training program for doctors and nurses who care for children with sickle cell disease. The goal is to help providers give better care and improve health outcomes for young patients with this blood disorder.
This trial tests whether a computer-based “attention control” training program can improve attention and daily functioning in children with sickle cell disease. To join, you must meet certain criteria and also pass an initial attention screening test during the study.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.